Frequency and clinical impact of hyperkalaemia within a large, modern, real‐world heart failure population

AIMS: This analysis qualitatively describes the impact of hyperkalaemia (HK) and renin‐angiotensin‐aldosterone system inhibitor (RAASi) use on clinical outcomes in patients with heart failure (HF). METHODS AND RESULTS: Patients were included if they were ≥18 years old; had a serum potassium result b...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ESC Heart Fail
Autors principals: Muhlestein, Joseph B., Kammerer, Jennifer, Bair, Tami L., Knowlton, Kirk U., Le, Viet T., Anderson, Jeffrey L., Lappé, Donald L., May, Heidi T.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Original Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7835576/
https://ncbi.nlm.nih.gov/pubmed/33331114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13164
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars